• Mashup Score: 2

    For some health conditions, there are multiple Cochrane reviews, each looking at the effects of a different intervention. Overviews of reviews are intended to help users to consider all interventions together and one of these overviews, for treating pain and disability in adults with complex regional pain syndrome was updated in June 2023. Here’s lead author, Michael Ferraro from Neuroscience Research Australia, to describe the findings. Your browser does not support the audio element. – Read transcript

    Tweet Tweets with this article
    • #CochranePodcast: Which treatments are effective for the management of complex regional #pain syndrome in adults? 🎧 Listen to the latest Cochrane evidence in under 3 minutes. https://t.co/5qmBtGHDiC

  • Mashup Score: 0

    Alongside their reviews on treatments for chronic kidney disease, the Cochrane Kidney and Transplant Group produce reviews for interventions that might help with its consequences. These were added to in August 2023 with a new review of ways to help manage the fatigue experienced by people requiring dialysis. Here’s lead author, Patrizia Natale from the University of Sydney in Australia, to tell us about the review. Your browser does not support the audio element. – Read transcript Mike: Hello, I’m Mike

    Tweet Tweets with this article
    • #CochranePodcast: Are interventions for fatigue effective among people with #kidney failure requiring #dialysis? 🎧 Listen to the latest Cochrane evidence in under 4 minutes! https://t.co/EOYQDruSx8 https://t.co/K0zYGFRoz5

  • Mashup Score: 1

    People with diabetes face additional challenges when they need treatments, such as surgery, for other conditions. In the August 2023 update to the Cochrane review, reviewers examined whether perioperative glycaemic control might help with this, and we asked joint lead author, Dídac Mauricio from the CIBER of Diabetes and Associated Metabolic Disease in Barcelona Spain to tell us more in this podcast. Your browser does not support the audio element. – Read transcript Mike: Hello, I’m Mike Clarke, podcast

    Tweet Tweets with this article
    • #CochranePodcast: What are the effects of intensive control of blood sugar before, during and after surgery in people with #diabetes? 🎧 Listen to the latest Cochrane evidence in under 4 minutes! https://t.co/N5aCdCtMhG https://t.co/pQ8wBpDEiK

  • Mashup Score: 4

    The Cochrane Pain, Palliative and Supportive Care Group has produced more than 300 reviews and added to these in August 2023 with a review of remotely-delivered psychological therapies for chronic pain in adults. Here’s one of the authors, Geoff Duggan formerly from the Bath Centre for Pain Services in the UK, to tell us about the importance of the review and its findings. Your browser does not support the audio element. – Read transcript Mike: Hello, I’m Mike Clarke, podcast editor for the Cochrane

    Tweet Tweets with this article
    • #CochranePodcast - Which remotely-delivered psychological approaches help people with long-term #ChronicPain to improve symptoms? 🎧 📚 Hear about the latest Cochrane evidence in under 4 minutes. https://t.co/DmIEnsqbiH https://t.co/Qcj1aYgsNw

  • Mashup Score: 0

    The Cochrane Breast Cancer Group have published reviews on more than 80 topics, and these were added to in September 2023 with a review of platinum-based chemotherapy for women with early stage triple negative breast cancer. In this podcast, Rachel Dear, co-author and breast cancer oncologist based in Sydney, talks with lead author, Sofia Mason from the Garvan Institute of Medical Research in Darlinghurst Australia about the findings. Your browser does not support the audio element. – Read transcript

    Tweet Tweets with this article
    • 🎧 #CochranePodcast Platinum-containing #chemotherapy for women before or after surgery for early triple-negative #BreastCancer Listen to the latest evidence from the Cochrane author in just 5 minutes. https://t.co/i6hUcE5r63 https://t.co/3INPWvGwFy

  • Mashup Score: 1

    Diabetic macular oedema is a common complication of diabetes, in which damage to the blood vessels at the back of the eye leads to swelling. Lucentis, Eylea and Avastin are three antiangiogenic drugs that can be injected into the eye to treat these blood vessels and reduce the swelling; and drugs with longer lasting effects have recently become available, such as Vabysmo and Beovue. In June 2023, Katie Curran from Queen’s University Belfast in the UK and colleagues, updated their Cochrane review of these

    Tweet Tweets with this article
    • #CochranePodcast - Anti-vascular endothelial growth factor (anti-VEGF) medicines for #diabetic macular oedema 🎧 Listen to the latest #diabetes evidence in under 3 minutes: https://t.co/hqgvrb7hsS 🤓 Read the full systematic review: https://t.co/oa3v3tg5OP https://t.co/eVI13mHCUY

  • Mashup Score: 4

    The Cochrane Tobacco Addiction Group has produced many reviews of the role of nicotine replacement therapy in smoking cessation and, in June 2023, they updated their review of different doses, durations and modes of delivery. Here’s first author, Annika Theodoulou from the Centre for Evidence-based Medicine at the University of Oxford in the UK to tell us about the latest findings. Your browser does not support the audio element. – Read transcript Mike: Hello, I’m Mike Clarke, podcast editor for the

    Tweet Tweets with this article
    • #CochranePodcast - What is the best way to use nicotine replacement therapy to #QuitSmoking? 🎧 Listen to the latest evidence in under 5 minutes: https://t.co/4PklHGk0CH 🤓 Read the full systematic review: https://t.co/NFNcdB7PUZ https://t.co/MEXu72fwNK